Please use this identifier to cite or link to this item:
|Title:||Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.|
|Authors:||Norman, Trevor R;Apostolopoulos, M;Burrows, Graham D;Judd, F K|
|Affiliation:||Department of Psychiatry, University of Melbourne, Austin Hospital, Victoria, Australia|
|Citation:||International Clinical Psychopharmacology; 9(2): 89-94|
|Abstract:||Prolactin and cortisol responses to buspirone, a partial serotonin agonist with effects on the 5-HT1A receptor, were measured in 16 patients with DSM-III-R obsessive-compulsive disorder (OCD) and 16 normal controls. No consistent differences were observed between patients and controls with respect to the hormone responses measured. The results suggest that dysfunction of the 5-HT1A receptor is not present in OCD patients. The limitations of buspirone as a specific agonist challenge of the 5-HT1A receptor are discussed. Although data from other studies generally support a serotonin dysfunction in OCD, the question of which specific subtype(s) of receptor remains unanswered.|
|Internal ID Number:||8056999|
Buspirone.adverse effects.therapeutic use
Obsessive-Compulsive Disorder.drug therapy.physiopathology
Receptors, Serotonin.drug effects
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.